15-Jun-2026 Tumor microenvironment responsive nanotherapeutics in cancer treatment: obstacles, opportunities and future prospects ELSP Peer-Reviewed Publication
14-Jun-2026 Integrating genetic origin data with tumour analyses enables better prediction of survival European Society of Human Genetics Reports and Proceedings
14-Jun-2026 ImmunoPRISM trial shows teclistamab improves depth of response and progression-free survival in high-risk smoldering multiple myeloma Dana-Farber Cancer Institute Business Announcement
14-Jun-2026 Fixed-duration triplet therapy demonstrates efficacy for patients with relapsed/refractory CLL Dana-Farber Cancer Institute Reports and Proceedings
13-Jun-2026 EDCs found in breast milk and infant urine up to age 6 months The Endocrine Society Reports and Proceedings
13-Jun-2026 Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy The Endocrine Society Reports and Proceedings
12-Jun-2026 Dana-Farber research supports FDA approval of pembrolizumab-belzutifan combination for higher-risk clear cell kidney cancer after surgery Dana-Farber Cancer Institute Business Announcement
12-Jun-2026 This is how to beat the tumor cells that survive cancer therapy University of California - San Francisco Peer-Reviewed Publication
12-Jun-2026 Montana State researcher discovers a critical cellular system that may one day lead to treatment of some cancers Montana State University Peer-Reviewed Publication